Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Asymmetric Chiral Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN114644614B details a novel 3-step synthesis for L-nicotine achieving >99.9% optical purity. Discover cost-effective, scalable manufacturing solutions for pharmaceutical intermediates.
Patent CN114644614B reveals a novel 3-step route to L-nicotine with >99.9% ee. Discover cost-effective manufacturing and supply chain advantages for pharma intermediates.
Discover a novel high-yield synthesis for S-pantoprazole sodium using sodium bismuthate. Enhanced optical purity and cost-effective manufacturing for global supply chains.
Patent CN114085219A details a high-ee synthesis of (1S,6R)-8-benzyl-7,9-dioxo-2,8-diazabicyclo[4.3.0]nonane. This route offers superior yield and purity for reliable pharmaceutical intermediate supply chains.
Patent CN102093166B details a scalable asymmetric synthesis of (S)-trans-1-yn-4-en-eicosan-3-ol with >97% ee, offering a reliable alternative to natural extraction for pharmaceutical applications.
Patent CN103772213A details a room-temperature copper-catalyzed route for (2S,3S)-2-amino-octadec-1,3-diol, offering significant cost reduction and high stereoselectivity for API manufacturing.
Patent CN105884781B details a chiral catalytic route for Tofacitinib Citrate, offering high purity and cost reduction in pharmaceutical intermediates manufacturing for global supply chains.
Patent CN102603714B details a high-yield asymmetric oxidation method for PPI intermediates. Discover cost-effective manufacturing and supply chain advantages.
Novel chiral catalytic route for Tofacitinib Citrate. Enhances purity, reduces cost, ensures supply chain reliability for pharmaceutical manufacturing.
Patent CN103951588A reveals a novel chiral squaramide catalytic route for saxagliptin intermediates, offering significant cost reduction and supply chain reliability for global pharmaceutical manufacturers.
Patent CN101323609A details a novel asymmetric oxidation method for high-purity PPI intermediates, offering significant cost reduction and supply chain reliability.
Patent CN102381990A details a cost-effective Ruthenium-catalyzed asymmetric hydrogenation route for N-benzyl phenylephrine intermediates, offering superior purity and supply chain reliability.
Patent CN103044402B details a low-cost chiral oxidation route for Esomeprazole Sodium, offering high purity and supply chain stability for API manufacturing.
Patent CN1926083B details a novel ruthenium-catalyzed asymmetric hydrogenation method for producing high-purity optically active alcohols with superior stereoselectivity and yield.
Patent CN109942514A reveals efficient Ir-catalyzed route for Atazanavir intermediate. Enables cost reduction in API manufacturing and reliable supply chain continuity.
Patent CN111333573A details a robust asymmetric hydrogenation process for dextromethorphan intermediates, offering superior enantioselectivity and scalable manufacturing advantages.
Patent CN102264672A details a scalable route to chiral phenols using Ru-catalyzed transfer hydrogenation, offering cost reduction and high purity for pharmaceutical manufacturing.
Patent CN102285896B details a novel chloramphenicol synthesis using benzaldehyde, offering high purity and reduced waste for reliable pharmaceutical intermediate supply chains.
Patent CN102984945B details a high-yield asymmetric hydrogenation process for Ramipril and Perindopril intermediates, offering significant cost and purity advantages for pharmaceutical supply chains.
Patent CN113980017A reveals a high-yield asymmetric hydrogenation route for tetrahydro-13-methyl berberine derivatives, offering significant cost reduction and scalability for pharmaceutical manufacturing.